2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1285155994 MD
Verify on CMS →

RABAIL SADIQ, MD

Endocrinology, Diabetes & Metabolism Physician in COLUMBIA, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
194
Medicare Part D claims · 38 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
43%
generic claims · 57% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$121.14
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RABAIL SADIQ, MD filed 194 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in COLUMBIA, Maryland, prescribing 43% generic.

194
Part D claims, 2023
43%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RABAIL SADIQ, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

194 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

RABAIL SADIQ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RABAIL SADIQ, MD?

Quality data not reported

NPI registry status

Active

Issued 07/03/2017

NPI 1285155994

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

194 93% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Maryland

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Maryland providers

Maryland providers

Endocrinology, Diabetes & Metabolism Physician share within Maryland

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Maryland

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RABAIL SADIQ, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 5755 CEDAR LN, COLUMBIA, MD, 21044, with a listed phone of (410) 720-8695. NPI 1285155994 was issued on 07/03/2017. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SADIQ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 194 prescription claims written by this provider, covering 38 Medicare beneficiaries and totaling roughly $100K in drug spend, split 57% brand-name and 43% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5755 CEDAR LN
COLUMBIA, MD 21044

Provider Details

NPI 1285155994
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 07/03/2017

Hospital and facility affiliations

Facilities where RABAIL SADIQ, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

JOHNS HOPKINS COMMUNITY PHYSICIANS, INC
BALTIMORE, MD
UPPER CHESAPEAKE ENDOCRINOLOGY ASSOCIATES, LLC
BEL AIR, MD

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RABAIL SADIQ, MD. Source: openpaymentsdata.cms.gov.

Total received

$121

Largest payer

Alexion Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

RABAIL SADIQ, MD — brand share 57.0%
Specialty average (est.)

57% brand-name claims vs 43% generic, on 194 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

194
Total Claims
$100K
Total Drug Cost
38
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
343
Total Day Supply
9,934
Brand vs Generic
57% brand / 43% generic
Brand Drug Cost
$97K

Patient Demographics

Average Patient Age
65.8 years
Avg HCC Risk Score
1.73
Age Distribution
<65: 13, 65-74: 16, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RABAIL SADIQ, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trulicity
Dulaglutide
33
Ozempic
Semaglutide
23
Metformin Hcl
16
Gabapentin
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How RABAIL SADIQ, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

RABAIL SADIQ, MD's 194 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Maryland

Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as SADIQ.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RABAIL SADIQ, MD's specialty?
RABAIL SADIQ, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in COLUMBIA, Maryland. Credentials: MD.
How much does RABAIL SADIQ, MD prescribe under Medicare Part D?
In 2023, RABAIL SADIQ, MD wrote 194 Medicare Part D claims totaling $100K in drug costs for 38 beneficiaries.
Where is RABAIL SADIQ, MD located?
RABAIL SADIQ, MD is located at 5755 CEDAR LN, COLUMBIA, MD, 21044. Phone: (410) 720-8695.
What is RABAIL SADIQ, MD's NPI number?
RABAIL SADIQ, MD's National Provider Identifier (NPI) is 1285155994, issued on 07/03/2017.
Does RABAIL SADIQ, MD prescribe more brand-name or generic drugs?
RABAIL SADIQ, MD's prescribing is 57% brand-name and 43% generic drugs by claim count, with $97K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does RABAIL SADIQ, MD prescribe most often?
Based on 2023 Medicare Part D data, RABAIL SADIQ, MD's most frequently prescribed drugs include Trulicity, Ozempic, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RABAIL SADIQ, MD accept Medicare?
RABAIL SADIQ, MD appears in CMS Medicare data with 194 Part D claims and 38 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RABAIL SADIQ, MD's credentials?
RABAIL SADIQ, MD's NPI is 1285155994 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology